news.

SZ2

Anfass Life Technologies in the spotlight: Dr. Giancarlo Rizzoli presents the groundbreaking innovations of 4D Lifetec, a portfolio company, in the Solothurner Zeitung newspaper

06.02.2024
Experience the future of cancer diagnostics through anfass Life Technologies AG, where 4D Lifetec, a prominent portfolio company, is leading the charge. In a recent in the local newspaper Solothurner Zeitung, Dr. Giancarlo Rizzoli, CEO of 4D Lifetec, sheds light on the groundbreaking strides made by the company.
Learn more…
Bild Press Release 2

4D Lifetec secures CHF 23.3 Mio in a share and investment deal with Xlife Sciences opening new horizons in using AI and digital health in early cancer detection.

20.10.2023
It is with great pleasure that we announce that our portfolio company, 4D Lifetec AG, has achieved a groundbreaking success. In close partnership with Xlife Sciences AG, 4D Lifetec not only receives a valuable financial investment of CHF 23.3 million, but also advanced AI technology. This innovation will pave the way for revolutionary early cancer detection and expansion of presence in the US. Read more about this milestone in the latest Genomweb post.
Learn more…
CPM2

Halder acquires majority stake in CPM Group

25.11.2022
Halder has acquired a majority stake in the family-run CPM Group. In doing so, the company is taking over a high-performance management team that has already been working together successfully in its composition for years. anfass Life Technologies has already been working with the Frankfurt-based financial investor Halder on various projects since 2020 and has provided a member of the CPM Group's advisory board since September 2022.
Learn more…